These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 38310440)

  • 1. Novel Biomaterials Based Strategies for Neurodegeneration: Recent Advancements and Future Prospects.
    Singh D; Nagdev S
    Curr Drug Deliv; 2024; 21(8):1037-1049. PubMed ID: 38310440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles.
    Kumar A; Zhou L; Zhi K; Raji B; Pernell S; Tadrous E; Kodidela S; Nookala A; Kochat H; Kumar S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity-based drug delivery systems for the central nervous system: exploiting molecular interactions for local, precise targeting.
    Ramos Ferrer P; Sakiyama-Elbert S
    J Neural Eng; 2024 Aug; 21(4):. PubMed ID: 39059438
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
    Popovic N; Brundin P
    Int J Pharm; 2006 May; 314(2):120-6. PubMed ID: 16529886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric Oxide-Releasing Biomaterials for Biomedical Applications.
    Zhou X; Zhang J; Feng G; Shen J; Kong D; Zhao Q
    Curr Med Chem; 2016; 23(24):2579-2601. PubMed ID: 27480214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring biomaterials for vaccine delivery.
    Zhuo Y; Zeng H; Su C; Lv Q; Cheng T; Lei L
    J Nanobiotechnology; 2024 Aug; 22(1):480. PubMed ID: 39135073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Maturitas; 2013 Nov; 76(3):272-8. PubMed ID: 23827471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain drug delivery systems for neurodegenerative disorders.
    Garbayo E; Ansorena E; Blanco-Prieto MJ
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2388-402. PubMed ID: 23016644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobiomaterials' applications in neurodegenerative diseases.
    Silva Adaya D; Aguirre-Cruz L; Guevara J; Ortiz-Islas E
    J Biomater Appl; 2017 Feb; 31(7):953-984. PubMed ID: 28178902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review.
    Mandal M; Jaiswal P; Mishra A
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22478. PubMed ID: 32124518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies.
    Giordano C; Albani D; Gloria A; Tunesi M; Batelli S; Russo T; Forloni G; Ambrosio L; Cigada A
    Int J Artif Organs; 2009 Dec; 32(12):836-50. PubMed ID: 20037888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinspired Approaches for Central Nervous System Targeted Gene Delivery.
    Kumar J; Karim A; Sweety UH; Sarma H; Nurunnabi M; Narayan M
    ACS Appl Bio Mater; 2024 Aug; 7(8):4975-4997. PubMed ID: 38100377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
    Gao H; Pang Z; Jiang X
    Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotheranostic agents for neurodegenerative diseases.
    Padmanabhan P; Palanivel M; Kumar A; Máthé D; Radda GK; Lim KL; Gulyás B
    Emerg Top Life Sci; 2020 Dec; 4(6):645-675. PubMed ID: 33320185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives.
    Maan G; Sikdar B; Kumar A; Shukla R; Mishra A
    Curr Top Med Chem; 2020; 20(13):1169-1194. PubMed ID: 32297582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.